Menu

Image of the Day: Blooming Algae

The British Phycological Society declares the winners of a photography contest for images of algae.

Jul 9, 2018
Sukanya Charuchandra
A living colony of Licmophora sp.
RAFAEL MARTÍN-LEDO

The British Phycological Society announced the winners of the Hilda Canter-Lund Annual Photography Award last week (July 4). Since 2009, the organization has given awards for photographs with an algal theme. 

This year’s winner is Rafael Martín-Ledo, an independent researcher from Spain, for his microscopy image of diatoms. Martín-Ledo fished a sample of the algae, which usually grow on flotsam, out of the Bay of Santander in Spain.

The first runner-up is John Huisman, the curator of the Western Australian Herbarium, for his underwater image of a type of red algae, called Ganonema, found off the northwest coast of Australia at Ashmore Reef.

Red algae Ganonema
John HUISMAN

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.